FDA Approved: ANTHIM — Original Application (Elusys Therapeutics, Inc.)

View source ↗

Summary

FDA approved ANTHIM (obiltoxaximab) from Elusys Therapeutics as an original application for the treatment of inhalational anthrax in combination with antibiotic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inhalational Anthrax

Drugs mentioned

• ANTHIM (obiltoxaximab)

Snippet

ORIG AP for ANTHIM (OBILTOXAXIMAB)